NCT06238466
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
Registry fields
- Overall status
- ACTIVE_NOT_RECRUITING
- Conditions
- Cardiovascular
- Study type
- INTERVENTIONAL
- Phase
- PHASE1
- Primary purpose
- TREATMENT
- Intervention type
- DRUG, OTHER
- Interventions
- AZD1705, Placebo
- Lead sponsor
- AstraZeneca (INDUSTRY)
Cached at: 2026-08-06 08:21:53
Brief summary
A study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD1705 in participants with dyslipidemia.
Contact
Need a report or Korean medical writing based on this trial?
Sign in with Kakao to continue